Calendar

Date TBD

ACTIVE_NOT_RECRUITINGphase readoutNCT05983068: A Study of Long-term Effect of Dupilumab on Skin Barrier Function in Pediatric Participants With Atopic Dermatitis

Sponsor: Sanofi. Phase: PHASE4. Conditions: Dermatitis Atopic

full page →ctgov ↗

COMPLETEDphase readoutNCT03531450: Central and Peripheral Effects of Cognitive Behavioral Therapy on Brain-Gut Axis Signaling in Gastroparetic Patients

Sponsor: Massachusetts General Hospital. Phase: NA. Conditions: Gastroparesis

full page →ctgov ↗

COMPLETEDphase readoutNCT01833650: The Use of Candy and Honey in Decreasing Salivary Gland Damage Following Radioiodine Therapy for Thyroid Cancer

Sponsor: Cyprus University of Technology. Phase: NA. Conditions: Thyroid Cancer

full page →ctgov ↗

COMPLETEDphase readoutNCT05022550: Virtual-reality and Emotion Regulation in Violence-Exposed Youth

Sponsor: University of Wisconsin, Madison. Phase: NA. Conditions: Emotional Regulation, Adolescent Behavior

full page →ctgov ↗

RECRUITINGphase readoutNCT05845450: Pre-operative Targeted Treatments in Molecularly Selected Resectable Colorectal Cancer (UNICORN)

Sponsor: Gruppo Oncologico del Nord-Ovest. Phase: PHASE2. Conditions: Colorectal Cancer, Resectable Colorectal Carcinoma

full page →ctgov ↗

COMPLETEDphase readoutNCT07346391: Augmentation of Peri-implant Keratinized Mucosa Using a Combination of Free Gingival Graft Strip With Platelet-Rich Fibrin

Sponsor: University of Medicine and Pharmacy at Ho Chi Minh City. Phase: NA. Conditions: Dental Implants

full page →ctgov ↗

RECRUITINGphase readoutNCT06902974: Psilocybin-Assisted Therapy for Sexual Assault-Related PTSD

Sponsor: Sunstone Medical. Phase: PHASE2. Conditions: Post Traumatic Stress Disorder, PTSD

full page →ctgov ↗

COMPLETEDphase readoutNCT04991974: Opioid Use Disorder Treatment Linkage at Strategic Touchpoints Using Buprenorphine

Sponsor: Friends Research Institute, Inc.. Phase: PHASE2. Conditions: Opioid-use Disorder

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07203274: The Role of Janus Kinase (JAK) and Voltage-gated Sodium Channels (Nav) on Pain and Itch

Sponsor: Aalborg University. Phase: NA. Conditions: Itchiness

full page →ctgov ↗

COMPLETEDphase readoutNCT00081874: RAD001 in Relapsed or Refractory AML, ALL, CML in Blastic-Phase, Agnogenic Myeloid Metaplasia, CLL, T-Cell Leukemia, or Mantle Cell Lymphoma

Sponsor: M.D. Anderson Cancer Center. Phase: PHASE1. Conditions: Leukemia, Mantle Cell Lymphoma, Myelofibrosis

full page →ctgov ↗

RECRUITINGphase readoutNCT07452874: Community-Based Occupational Therapy for Syrian Refugees to Improve Social Participation and Occupational Justice

Sponsor: Kocaeli University. Phase: NA. Conditions: Refugees, Occupational Injustice

full page →ctgov ↗

RECRUITINGphase readoutNCT07532018: DXP-106 in Solid Tumor Patients.

Sponsor: Singlomics Biopharmaceuticals Zhuhai Co., Ltd.. Phase: PHASE1. Conditions: Solid Tumor, Cancer

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07695818: Testing and Evaluation of the Returning to the Land Intervention to Address and Prevent Substance Misuse

Sponsor: Johns Hopkins Bloomberg School of Public Health. Phase: NA. Conditions: Substance Use, Children, Cultural Factors

full page →ctgov ↗

COMPLETEDphase readoutNCT05766813: Lenrispodun as Adjunctive Therapy in the Treatment of Patients With Motor Fluctuations Due to Parkinson's Disease

Sponsor: Intra-Cellular Therapies, Inc.. Phase: PHASE2. Conditions: Parkinson Disease

full page →ctgov ↗

RECRUITINGphase readoutNCT07092813: Pharmacokinetics of Sulopenem Etzadroxil Plus Probenecid in Adolescents

Sponsor: Iterum Therapeutics, International Limited. Phase: PHASE1. Conditions: Pharmacokinetics After Oral Intake

full page →ctgov ↗

COMPLETEDphase readoutNCT05760313: A Study to Assess Adverse Events and Change in Disease Activity in Pediatric Participants (Age 6 Months to <2 Years) With Functional Constipation Who Are Treated With Linaclotide

Sponsor: AbbVie. Phase: PHASE2. Conditions: Functional Constipation

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT06740110: Bone Material's Histomorphometric Analysis In Socket Preservation

Sponsor: Medical Inventi S.A.. Phase: NA. Conditions: Socket Preservation

full page →ctgov ↗

COMPLETEDphase readoutNCT02838420: A Study to Evaluate and Compare the Efficacy and Safety of Alectinib Versus Crizotinib and to Evaluate the Pharmacokinetics of Alectinib in Asian Participants With Treatment-Naive Anaplastic Lymphoma Kinase (ALK)-Positive Advanced Non-Small Cell Lung Cancer (NSCLC)

Sponsor: Hoffmann-La Roche. Phase: PHASE3. Conditions: Anaplastic Lymphoma Kinase-positive Non-small Cell Lung Cancer

full page →ctgov ↗

COMPLETEDphase readoutNCT04433520: Trevisio Post-Approval Study

Sponsor: Abbott Medical Devices. Phase: . Conditions: PFO - Patent Foramen Ovale, ASD - Atrial Septal Defect, VSD - Muscular Ventricular Septal Defect, PIVSD - Post Infarct Muscular Ventricular Septal Defect

full page →ctgov ↗

COMPLETEDphase readoutNCT07366320: Effects of Four-Week Rhodiola Rosea Supplementation on Physical Fitness, Neuromuscular Performance, and Decision-Making in Competitive Football Players

Sponsor: Beijing Sport University. Phase: NA. Conditions: Physical Performance and Fatigue in Competitive Football Players

full page →ctgov ↗

COMPLETEDphase readoutNCT02220920: Efficacy and Safety Study of Canagliflozin (TA-7284) in Combination With Insulin in Patients With Type 2 Diabetes Mellitus

Sponsor: Tanabe Pharma Corporation. Phase: PHASE4. Conditions: Type 2 Diabetes Mellitus

full page →ctgov ↗

COMPLETEDphase readoutNCT05552820: Electroacupuncture for Mild-to-moderate Dry Eye

Sponsor: Shanghai Institute of Acupuncture, Moxibustion and Meridian. Phase: NA. Conditions: Dry Eye

full page →ctgov ↗

RECRUITINGphase readoutNCT06821282: Surveillance of AMR in DRC

Sponsor: University of Oxford. Phase: . Conditions: Bacteremia

full page →ctgov ↗

RECRUITINGphase readoutNCT06315582: Surgical Approach to Uterine Septum

Sponsor: Northwestern University. Phase: NA. Conditions: Uterine Septum, Surgical Complication, Septum; Uterus, Treatment Side Effects, Treatment

full page →ctgov ↗

AVAILABLEphase readoutNCT06751524: Expanded Access Program (EAP) Designed to Provide Access to Botensilimab and Balstilimab Before Regulatory Approval

Sponsor: Agenus Inc.. Phase: . Conditions: Colorectal Cancer (CRC), Pancreatic Cancer, Non-Small Cell Lung Cancer (NSCLC), Hepatocellular Carcinoma (HCC), Melanoma, Sarcoma, Ovarian Cancer, Prostate Cancer

full page →ctgov ↗

RECRUITINGphase readoutNCT07480824: To Evaluate the Pharmacokinetics and Safety of TQ05105 Tablet in Hepatic Impairment Subjects

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.. Phase: PHASE1. Conditions: Myelofibrosis

full page →ctgov ↗

RECRUITINGphase readoutNCT07467824: Impact of Prehabilitation and Comprehensive Follow-up in Women With Breast Cancer

Sponsor: European University Miguel de Cervantes. Phase: NA. Conditions: Breast Cancer, Breast Neoplasms

full page →ctgov ↗

COMPLETEDphase readoutNCT07352124: Rosemary Infusion for Hypertension With Hypertriglyceridemia

Sponsor: awatef Sassi. Phase: NA. Conditions: Hypertension With Hypertriglyceridemia

full page →ctgov ↗

RECRUITINGphase readoutNCT06637423: A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027)

Sponsor: Merck Sharp & Dohme LLC. Phase: PHASE1. Conditions: Non-Muscle Invasive Bladder Cancer

full page →ctgov ↗

RECRUITINGphase readoutNCT07400523: Ribociclib in Hormone Receptor-positive, HER2-negative Early Breast Cancer With Residual Disease After Neoadjuvant Chemotherapy

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University. Phase: PHASE3. Conditions: Breast Cancer

full page →ctgov ↗

RECRUITINGphase readoutNCT06776523: Boosting Refugee Integration Through Psychological Intervention

Sponsor: University of Zurich. Phase: NA. Conditions: Psychological Distress, PTSD, Trauma, Common Mental Health Problems

full page →ctgov ↗

RECRUITINGphase readoutNCT05411523: Assessing Effect of Spinal Cord Stimulation on Pain and Quality of Life With Chemotherapy-Induced Peripheral Neuropathy

Sponsor: Mayo Clinic. Phase: . Conditions: Chemotherapy-Induced Peripheral Neuropathy, Hematopoietic and Lymphoid System Neoplasm, Malignant Solid Neoplasm

full page →ctgov ↗

COMPLETEDphase readoutNCT05610059: Improving Hypertension Medication Adherence for Older Adults

Sponsor: University of Arizona. Phase: NA. Conditions: Aging, Medication Adherence, Hypertension

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07580859: Antenatal vs Postnatal Transport Team Positioning in Extremely Preterm Outborn Infants

Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: . Conditions: Prematurity Complications, Neurodevelopment Outcome, Prematurity

full page →ctgov ↗

RECRUITINGphase readoutNCT07716059: Legume Flour Particle Size and Metabolic Responses to Bread

Sponsor: Harokopio University. Phase: NA. Conditions: Type 2 Diabetes

full page →ctgov ↗

TERMINATEDphase readoutNCT05044780: Hyperspectral Analysis of Sweat Metabolite Biometrics for Real-Time Detection of COVID-19

Sponsor: National Cancer Institute (NCI). Phase: . Conditions: COVID-19

full page →ctgov ↗

RECRUITINGphase readoutNCT05568680: SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma

Sponsor: Verismo Therapeutics. Phase: PHASE1. Conditions: Ovarian Cancer, Cholangiocarcinoma Recurrent, Mesothelioma, Malignant

full page →ctgov ↗

RECRUITINGphase readoutNCT07479680: Effect of Direct Chin-tuck Against Resistance on Swallowing Function

Sponsor: National Taiwan University Hospital. Phase: NA. Conditions: Dysphagia

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT07661680: Perianchor Cyst Formation, Tendon Healing, and Clinical Outcomes Following Arthroscopic Rotator Cuff Repair

Sponsor: Fatih Sultan Mehmet Training and Research Hospital. Phase: . Conditions: Rotator Cuff Tears, Tendon Thickening, Tendon Injuries, Muscle Weakness

full page →ctgov ↗

RECRUITINGphase readoutNCT06297980: Impact of MEnstruation on Glycemic Response and Exercise In Females With Type 1 Diabetes

Sponsor: University of Colorado, Denver. Phase: NA. Conditions: Type 1 Diabetes, Hypoglycemia, Hyperglycaemia Due to Type 1 Diabetes Mellitus, Menstruation Disturbances

full page →ctgov ↗

COMPLETEDphase readoutNCT05646680: A Performance Study of (Opportunistic) Salpingectomy

Sponsor: University Hospital, Ghent. Phase: NA. Conditions: Adnexal Lesion, Ovarian Cancer

full page →ctgov ↗

RECRUITINGphase readoutNCT07357779: Clinical Efficacy and Health Economic Evaluation of an Intelligent Diagnostic and Treatment Model

Sponsor: Zan Wang. Phase: NA. Conditions: Insomnia

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT07521579: A School-based to Prevent Obesity Among Children Aged 4-7 Years- A Feasibility Quasi-Experimental Trial in Karachi, Pakistan

Sponsor: Dow University of Health Sciences. Phase: NA. Conditions: Childhood Obesity

full page →ctgov ↗

COMPLETEDphase readoutNCT06660979: Using Reinforcement Learning to Personalize Electronic Health Record Tools to Facilitate Deprescribing

Sponsor: Brigham and Women's Hospital. Phase: NA. Conditions: Aging

full page →ctgov ↗

COMPLETEDphase readoutNCT07472179: Effect of Pioglitazone vs Metformin on Clinical, Biochemical and Hormonal Parameters of Insulin Resistant PCOS

Sponsor: Mst.Sumyara Khatun. Phase: NA. Conditions: PCOS(Insulin Resistant)

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07322679: Dihydroberberine Effects on Body Composition and Metabolic Health in Healthy Adults

Sponsor: Nanjing Nutrabuilding Bio-tech Co., Ltd.. Phase: NA. Conditions: Health Adult Subjects

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT06633562: A Study to Test the Effects of Nezavist at Different Doses in Healthy Adults

Sponsor: Lohocla Research Corporation. Phase: PHASE1. Conditions: Healthy, Safety Evaluation of Escalating Doses, Tolerability

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT06447662: A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation.

Sponsor: Pfizer. Phase: PHASE1. Conditions: Carcinoma, Pancreatic Ductal, Colorectal Neoplasms, Carcinoma, Non-Small-Cell Lung

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07698262: Brain-based Prediction of the Dying Duration in Humans After Withdrawal of Life Sustaining Therapies to Inform Donation After Circulatory Death

Sponsor: University of British Columbia. Phase: . Conditions: Organ Donation After Circulatory Death

full page →ctgov ↗

RECRUITINGphase readoutNCT06517862: Efficacy & Safety of Oral Adjuvants to Phototherapy in Neonatal Hyperbilirubinemia

Sponsor: Amira Adel Fouly. Phase: PHASE4. Conditions: Neonatal Hyperbilirubinemia

full page →ctgov ↗

Date TBD